Mabwell(Shanghai) Bioscience Co.,Ltd. Posted 415.9 Million Yuan Net Loss in First Half of 2023

Mabwell(Shanghai) Bioscience Co.,Ltd. (迈威(上海)生物科技股份有限公司) (688062.SH) reported a net loss of 415.9 million yuan in the first half of 2023, narrowing 2.3% year-on-year.

Meanwhile, the company posted 90 million yuan in revenue, up 713.8% year-on-year.

At the end of the reporting period, it had 4.7 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 32.2%.